BRPI0905917A2 - Vírus mutante da família flaviviridae, composição farmacêutica, ácido nucléico, proteína de capsídeo de vírus mutado, método para produzir um vírus modificado e método para produzir um ácido nucléico modificado - Google Patents
Vírus mutante da família flaviviridae, composição farmacêutica, ácido nucléico, proteína de capsídeo de vírus mutado, método para produzir um vírus modificado e método para produzir um ácido nucléico modificadoInfo
- Publication number
- BRPI0905917A2 BRPI0905917A2 BRPI0905917-2A BRPI0905917A BRPI0905917A2 BR PI0905917 A2 BRPI0905917 A2 BR PI0905917A2 BR PI0905917 A BRPI0905917 A BR PI0905917A BR PI0905917 A2 BRPI0905917 A2 BR PI0905917A2
- Authority
- BR
- Brazil
- Prior art keywords
- virus
- producing
- nucleic acid
- modified
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08101404 | 2008-02-08 | ||
PCT/EP2009/051351 WO2009098277A1 (en) | 2008-02-08 | 2009-02-06 | Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0905917A2 true BRPI0905917A2 (pt) | 2015-08-04 |
Family
ID=40673966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0905917-2A BRPI0905917A2 (pt) | 2008-02-08 | 2009-02-06 | Vírus mutante da família flaviviridae, composição farmacêutica, ácido nucléico, proteína de capsídeo de vírus mutado, método para produzir um vírus modificado e método para produzir um ácido nucléico modificado |
Country Status (8)
Country | Link |
---|---|
US (1) | US8715999B2 (pt) |
EP (1) | EP2240509A1 (pt) |
JP (1) | JP2011510672A (pt) |
CN (1) | CN101970467A (pt) |
AU (1) | AU2009211379B2 (pt) |
BR (1) | BRPI0905917A2 (pt) |
CA (1) | CA2713400A1 (pt) |
WO (1) | WO2009098277A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT410634B (de) * | 2001-02-21 | 2003-06-25 | Franz X Dr Heinz | Attenuierte lebendimpfstoffe |
DK2717893T3 (da) | 2011-06-08 | 2019-07-22 | Translate Bio Inc | Lipid nanopartikelsammensætninger og fremgangsmåder til mrna-levering |
CN113215117B (zh) * | 2021-05-17 | 2022-09-06 | 四川农业大学 | 一种鸭坦布苏病毒致弱活疫苗候选株及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443965A (en) * | 1990-04-06 | 1995-08-22 | Genelabs Incorporated | Hepatitis C virus epitopes |
US7227011B2 (en) * | 1998-06-04 | 2007-06-05 | United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Nucleic acid vaccines for prevention of flavivirus infection |
CN1549730A (zh) * | 2000-10-04 | 2004-11-24 | ���������Ǵ�ѧ�й��� | 黄病毒和瘟病毒衣壳蛋白的组成和使用方法 |
AT410634B (de) * | 2001-02-21 | 2003-06-25 | Franz X Dr Heinz | Attenuierte lebendimpfstoffe |
MXPA05001644A (es) * | 2002-08-13 | 2005-04-19 | Akzo Nobel Nv | Replicones de pestivirus que no expresan proteina c y/o e1, y particulas virales infecciosas que los contienen y pueden usarse en vacunas. |
-
2009
- 2009-02-06 AU AU2009211379A patent/AU2009211379B2/en not_active Ceased
- 2009-02-06 BR BRPI0905917-2A patent/BRPI0905917A2/pt not_active Application Discontinuation
- 2009-02-06 WO PCT/EP2009/051351 patent/WO2009098277A1/en active Application Filing
- 2009-02-06 JP JP2010545473A patent/JP2011510672A/ja active Pending
- 2009-02-06 CA CA2713400A patent/CA2713400A1/en not_active Abandoned
- 2009-02-06 EP EP09707152A patent/EP2240509A1/en not_active Withdrawn
- 2009-02-06 US US12/866,631 patent/US8715999B2/en not_active Expired - Fee Related
- 2009-02-06 CN CN2009801044150A patent/CN101970467A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN101970467A (zh) | 2011-02-09 |
US8715999B2 (en) | 2014-05-06 |
JP2011510672A (ja) | 2011-04-07 |
US20100323003A1 (en) | 2010-12-23 |
AU2009211379B2 (en) | 2014-08-21 |
AU2009211379A1 (en) | 2009-08-13 |
CA2713400A1 (en) | 2009-08-13 |
EP2240509A1 (en) | 2010-10-20 |
WO2009098277A1 (en) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0814939A2 (pt) | Entidade química, composição farmacêutica, e, método para tratar uma infecção viral em um mamífero. | |
BRPI1011764A2 (pt) | composição farmacêutica, e, método para preparar uma composição farmacêutica | |
BRPI0916689A2 (pt) | composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida. | |
BRPI0921651A2 (pt) | Método para produzir adenovírus recombinante, e partículas virais, e, biorreator | |
BR112014002621A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento | |
IL210485A (en) | An isolated antibody or its functional protein, a process for making it, a pharmaceutical preparation containing it, and an isolated amino acid encoding an antibody or a functional protein | |
BRPI0906804A2 (pt) | Método para liofilizar partículas, e, acondicionamento farmacêutico | |
BRPI1006141A2 (pt) | composições de anticorpo modificado, métodos para preparar e usar as mesmas | |
BRPI0905717A2 (pt) | Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica | |
BRPI0922173A2 (pt) | preparação farmacêutica, e, método para preparar uma preparação farmacêutica | |
BR112012009609A2 (pt) | método para fabricar uma dispersão sólida, dispersão sólida , preparação farmacêutica e composições | |
BRPI1008145A2 (pt) | proteína de ligação de antígeno biespecífico, método para preparação de uma proteína de ligação de antígeno biespecífico, célula hospedeira, composição farmacêutica, uso da proteína de ligação de antígeno biespecífico e método para o tratamento de um paciente. | |
BRPI0807597A2 (pt) | Composição farmacêutica, e, método para tratar infecção por vírus da influenza | |
BRPI0818680A2 (pt) | composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica | |
BRPI0912403A2 (pt) | pasta aquosa, concreto, e, métodos para preparar uma pasta aquosa e para preparar um concreto | |
EP1989316A4 (en) | METHOD FOR THE PRODUCTION OF RECOMBINANT VIRUS, DNA CONSTRUCTS, RECOMBINANT VIRUS AND VACCINE COMPOSITIONS | |
IL217016A0 (en) | Method for replicating influenza virus in culture | |
BRPI0811499A2 (pt) | Métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral. | |
BRPI1007161A2 (pt) | composição farmacêutica oral, e processo para preparar uma composição | |
BRPI0921507A2 (pt) | composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo | |
BRPI0719272A2 (pt) | Composição de enzima, e, método para preparar uma composição de enzima. | |
BRPI0912539A2 (pt) | composto, composição farmacêutica , método para tratar uma doença, e, uso do composto. | |
BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
BRPI0919485A2 (pt) | vacinas, antígenos, composições de plasmodium e métodos | |
BRPI1007211A2 (pt) | composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |